Altria’s Dividend Yield Signals Doubts About the Payout. Why It’s Safe.

The FDA’s bid to ban Juul products—like these at a shop in El Segundo, Calif., on a recent day—has weighed on Altria stock. Analysts think Altria, which has a big stake in Juul, will be able to ...

Juul Ban Will Send Altria’s Strategy, and $13 Billion, Up in Smoke

Altria Group disastrous investment in Juul Labs is taking another turn for the worse. On Wednesday, The Wall Street Journal reported that the Food and Drug Administration is preparing to remove Juul e...

Altria’s Cigarette Addiction Is Becoming Unhealthier

For years tobacco companies have been fighting regulators more than each other. That might be about to change, and Altria MO -0.61% in particular needs a game plan. If Philip Morris International’s PM...

Why Altria’s Stock Could Be a Buy and Philip Morris Isn’t

Text size Analyst Bonnie Herzog raised her rating on Altria to Buy from Neutral and her price target to $57 from $48 Fabrice Coffrini/AFP via Getty Images Altria Group has been the standout in Big Tob...